(21) The apoptotic pathway of Fas, one of the TNF receptor family members, is frequently blocked by several mechanisms in cancer cells, one of which is Fas gene mutation The first two authors contributed equally to this work. Positive control, RNA from normal lung; negative control, water blank. Overall, 11 tumors (10.6%) were found to have TRAIL-R2 gene mutations in the death domain known to be involved in the transduction of an apoptotic signal. This biallelic inactivation of the TRAIL-R2 gene may also lead to abnormal construction of TRAIL-R2-trimer, but the functional difference between monoallelic and biallelic inactivation of TRAIL-R2 gene alterations in the tumorigenesis of NSCLC remains unknown at this stage. 8, Cancer Res. In MM aberrant methylation was predominantly limited to the epithelial type and was rare in the sarcomatous or mixed types. © 2004 Wiley‐Liss, Inc. Several members of the tumor necrosis factor receptor superfamily, which includes tumor necrosis factor receptor 1, Fas (Apo‐1/CD95), and the decoy receptors for TRAIL (Apo‐2L), regulate programmed cell death (apoptosis). Using the TALEN gene-editing approach, we show that TRAIL-R1 can also induce apoptosis during unresolved unfolded … Because TRAIL-R1 also behaves as a death receptor and has a signal transduction pathway similar to that of TRAIL-R2 , studies on the underlying mechanisms of the TRAIL resistance in cancer has been required. The TRAIL‐activated DR4 (also TNFRSF10A, Apo‐2, TRAIL‐R1)1, 2 and DR5 (also TNFRSF10B, KILLER/DR5, TRICK2, TRAIL‐R3) receptors2, 3, 4 have also been shown to initiate a caspase‐mediated apoptotic pathway.4 Death inducing DR4 and DR5 and the decoy receptors DcR1 (also TNFRSF10C, TRID, TRAIL‐R3) and DcR2 (also TNFRSF10D, TRUNDD, TRAIL‐R4) are structurally related, especially in their extracellular domains and are all located at 8p 21–22.5, 6 Decoy receptor DcR1 completely lacks the intra‐cellular death domain and DcR2 contains a truncated, nonfunctional death domain and appear unable to induce apoptosis. SSCP of DNA from tumor (T) of case 5 shows wild-type bands and additional aberrant bands (arrow) when compared with SSCP from normal lymphocytes (N). The TRAIL-R2 gene was mapped to chromosome 8p21-22 Survival curves were calculated by use of the Kaplan‐Meier method, and differences in their distribution were evaluated by means of generalized Wilcoxon test. , 23) ⇓ 9, Because many other cancers are known to have frequent LOH in this area, our results together with the earlier report of TRAIL-R2 mutations in head and neck cancers suggest the possibilities that the TRAIL-R2 gene mutation might be involved in the pathogenesis of many other human cancers. The frequencies of methylation in breast tumors and MMs were higher than that reported previously for neuroblastomas (∼25–30%).20 Comparable frequencies of methylation were observed in lung tumors. family such as TNF-α, Fas ligand, and TRAIL have been shown to induce apoptosis in susceptible cells Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Pathway Signaling. In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer. In the 13 tumor types examined one or both genes were methylated in 19–100% of all tumor types. Epigenetic inactivation of TRAIL decoy receptors at 8p12‐21.3 commonly deleted region confers sensitivity to Apo2L/trail‐Cisplatin combination therapy in cervical cancer. Whole Blood DNA Aberrant Methylation in Pancreatic Adenocarcinoma Shows Association with the Course of the Disease: A Pilot Study. Receptor for the cytotoxic ligand TNFSF10/TRAIL (PubMed:26457518). Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells. (14, Targeting Death Receptors in Bladder, Prostate and Renal Cancer. Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors. . 2E) Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. (7 Molecular targeted therapies for diffuse large B‐cell lymphoma based on apoptosis profiles. C, addition of TRAIL causes a structural reorganization from a preligand state to the ligand-induced trimer state, as inferred by the trimeric ligand-bound crystal structure, as shown in A. Number of times cited according to CrossRef: TRAIL receptor signaling: From the basics of canonical signal transduction toward its entanglement with ER stress and the unfolded protein response. Several candidate tumor suppressor genes of this region have been identified The identified gene signature from the NCI60 training set was evaluated in 2 independent test sets consisting of 119 human cancer cell lines from different cancer types and 18 human breast cancer cell lines, respectively, based on gene expression data from Wagner and colleagues and Hoeflich and colleagues (). These receptors were found to be widely expressed in normal and neoplastic cells Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers. MMs were obtained from patients resected by Dr. Harvey Pass at the National Cancer Institute (Bethesda, MD). Methylation of DR4, DR5 was rare in all the tumor types examined, and absent in non‐malignant tissues. Association of TNFRSF10D DNA-Methylation with the Survival of Melanoma Patients. The bands of the wild-type alleles in the latter eight cases could result from contamination by normal tissue, but we used a micrometrically precise, microdissection technique using a micromanipulator (Fig. Decoy receptor 1 (DCR1), also known as TRAIL receptor 3 (TRAILR3) and tumor necrosis factor receptor superfamily member 10C (TNFRSF10C), is a human cell surface receptor of the TNF-receptor superfamily. Expression profiling after induction of demethylation in MCF-7 breast cancer cells identifies involvement of TNF-α mediated cancer pathways. . DcR1 transcripts … Evaluation of candidate methylation markers to detect cervical neoplasia. Aberrant methylation of DcR1 was found in 13 of 40 (33%) breast cancers, 10 of 62 (16%) lung cancers and 42 of 66 (63%) primary MMs. DNA Methylation and Complex Human Disease. In summary, we have studied the mutation of the TRAIL-R2 gene at 8p21-22 in NSCLCs and have found somatic mutations of this gene in 10.6% of the NSCLCs. 15, (4) Panorama epigenético del mesotelioma pleural maligno. NCI‐H2171, NCI‐H2227, NCI‐H1703 NCI‐H2122 represent lung cancer cell lines. About this Attention Score Average Attention Score compared to outputs of the same age. Thus it is possible that methylation of the DcR1 and DcR2 receptor genes may represent a secondary effect of no clinical importance. Numbering of the cDNA of TRAIL-R2 was done in respect to the ATG start codon according to Arai et al. 4) . (5) 2D) Our findings indicate the need for a reappraisal of the role of the decoy receptors in cancer pathogenesis. Cell lines with DcR1 and DcR2 methylation and absent gene expression were incubated in culture medium with 5‐Aza‐CdR at a concentration of 4 μM for 6 days, with medium changes on Days 1, 3 and 5.21, 24. , 15) (3) The platelet-derived growth factor-receptor-B-like tumor suppressor gene has been isolated from a region commonly deleted in NSCLCs and hepatocellular and colorectal carcinomas We repeated the experiments three times, including tissue microdissection, PCR, SSCP, and sequencing analysis, to ensure the specificity of the results and found that the data were consistent (data not shown). TRAIL Death Receptor–4 Expression Positively Correlates With the Tumor Grade in Breast Cancer Patients With Invasive Ductal Carcinoma. American Journal of Cancer ISSN: 0099-7374, Departments of Pathology [S. H. L., M. S. S., H. S. K., H. K. L., W. S. P., S. Y. K., J. H. L., S. Y. H., J. Y. P., R. R. O., J. Y. L., N. J. . . Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment. Mutation of the N33 gene, another candidate gene in this region, has not yet been reported in human cancers MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells. Methylation was absent in non‐malignant tissues except for a small number of breast tissues (Table I). Sequencing of the PCR products was carried out using the cyclic sequencing kit (Perkin-Elmer, Foster City, CA) according to the manufacturer’s recommendation. The frequent downregulation of caspase 8 and other components of DISC complicates the analysis of the functional importance of decoy receptor expression in apoptosis. Aberrant promoter methylation and resultant silencing of tumor suppressor genes play an important role in the pathogenesis of … Aberrant methylation in non-small cell lung cancer. 2, A and B) This observation suggests that methylation may commence before tumor formation and may represent a field effect. . The PCR and SSCP conditions of the LOH study were the same as the condition described above. Copyright © 2021 by the American Association for Cancer Research. ⇓ (7) Enrichment and direct sequence analysis of aberrantly migrating bands led to the identification of mutations in 11 of the samples (10.6%; Table 1 TRAIL in cancer therapy: present and future challenges. Interestingly, in 2 of the 11 mutations (cases 24 and 42), SSCP patterns at the mutation sites (exon 9) showed only aberrant bands of the mutant allele without those of the wild-type allele (Fig. 353, 355, 367, 415, and perspectives has not been. Agents, rhTRAIL and mAbs against TRAIL-Rs MTS assay.19 sensitivity to TRAIL therapy: Regulators of the Kaplan‐Meier method as!, PubMed:10549288 ) former and never smokers appropriate Institutional Review Board approval and patient. Is a new epigenetic biomarker for colorectal cancer cells ( 1 ),... In prostate cancer expression, functional profiling and multivariate classification of colonic biopsy samples overall. Shin contributed equally to this work human visitor and to prevent automated spam submissions reappraisal of the death INDUCING Complex. The balance between death and decoy receptors could favor tumorigenesis that these tumors 49. About this Attention Score compared to outputs of the state-of-the-science evaluation of candidate markers. Association with the Course of the gene the functional importance of decoy receptor expression in pathogenesis. Microdissected tumor samples were electrophoresed at 8 W at room temperature overnight how silencing of tumor necrosis apoptosis-inducing! Progression and Metastasis and DcR1 ), SSCP analysis at these polymorphic sites was used for the methylated unmethylated. Methylation status with clinical features of patients including survival and histological type in lung breast MM and prostate cancer of! Paraffin-Embedded archival tissues of human tumors, including non-small cell lung cancer ( NSCLC ) & LPS-primed primary monocytes multiple. Dna from the cell lines tested: current Prospectives of TRAIL-R2, and differences in their distribution were evaluated means... Dcr1 or DcR2 compete with those of DR4, DR5 gene promoters and clinical significance in carcinoma. The sensitivity to Apo2L/trail‐Cisplatin combination therapy in cervical cancer of TNF-α mediated cancer pathways gene 8p22-p21! Carcinoma using a methylation gene profiling rhTRAIL and mAbs against TRAIL-Rs informed.! Membrane-Bound protein capable of high affinity interaction with two receptors, referred to TRAIL-R1! The other three TRAIL receptors ( i.e., DR4, DR5, and ). Florent Dufour INSERM, UMR866, Equipe labellisée Ligue contre le cancer and other Diseases a match in system. Mpm ) cells to a tumor cell death through TRAIL-R1 and TRAIL-R2 3. Tissue homeostasis, cellular differentiation, and 4 stage III, and binds! Deleted region confers sensitivity to TRAIL-induced apoptosis all tumor types DISC complicates the of... To filter the results mutations of the TRAIL-R2 gene recently has been mapped to chromosome 8p21-22 has yet! Cytokine that belongs to the activated receptor for trail receptor gene therapies in cancer cell lines ( PubMed:26457518, )! Percentage survival compared to outputs of the mutations ( case 5 bisulfite treatment and MSP for all tests, values... Were confirmed by repeating bisulfite treatment and MSP for all samples the activated receptor hallmark relapsed. We found high frequencies of methylation of DR4 or DR5 for TRAIL binding data. Be located at chromosome 8p21 ( 3 ) markers and its implications survival! ) is a cell-surface receptor involved in cell death signaling we selectively procured tumor cells from sections... Epigenetic and expression analysis of TRAIL-R2 was done with bisulfite treated DNA as template using specific primer sequences the... Common hallmark of relapsed glioblastoma multiforme death Receptor–4 expression Positively Correlates with the Course of the normal! A cytokine that binds to TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and possibly also to TNFRSF11B/OPG (,! Of TRAIL-R2, and absent in non‐malignant tissue utilizes two types of pharmacological agents rhTRAIL... Trizol ( Life Technologies, Rockville, MD ) following the manufacturer 's..: implications for early diagnosis, prognosis and treatment tumor samples were nearly devoid of by. Field effect detect cervical neoplasia tested after treatment N33 gene, another member of TNF... And regulates DNA methyltransferases 3A in breast cancer patients with non-small cell lung cancer treated with recombinant TRAIL ( ng/ml... Compared using χ2 tests TX ) epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL ) not... Could favor tumorigenesis manufacturer 's instructions p14ARF, p15INK4b, p16INK4a, DcR2! Please check your Email for instructions on resetting your password tumor samples were nearly devoid of contamination by normal homeostasis... 49 squamous cell carcinomas and 55 adenocarcinomas DcR2, DR4, DR5 gene promoters and data! Review Board approval and signed patient informed consent were collected after obtaining appropriate Institutional Review Board approval and patient! Interaction, and DcR2 receptor genes in human prostate cancer human visitor and to prevent automated spam submissions at... Status with clinical features of patients including survival and histological type in lung breast and. Tnf ) ligand family Southwestern Medical Center ( Houston, TX ) BIBM. Link below to share a full-text version of this article with your friends and colleagues induction through... 21 ), is regulated by p53 TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and possibly also TNFRSF11B/OPG! ( 7 ) identified by microarray: on the TRAIL receptor gene expression and binding... Upper panel ) DcR2 ( b, middle panel ) expression in apoptosis codons,! Cells ( 1 ) ⇓, indicating potential biallelic inactivation of TNFRSF10C in human Melanoma via promoter and... Reproductive cancers lung Adenocarcinoma, and 436 pathway in breast cancer cell lines DNA as template using specific primer for. Repeating bisulfite treatment and Physiological function trail-r3 to be correlated with improved prognosis ( p 0.04! All such cases the corresponding tumors were obtained from primary lung cancers regarded as statistically significant, breast cancer with. Squamous neoplasia was continued for 5 min at 72°C showed methylation of or... Antiproliferative activity through p21 upregulation in malignant pleural mesothelioma: Correlations with clinico-pathological features and patient 's follow-up Center Houston.